Consumer edition active

Common Side Effects of Some Oral Antihyperglycemic Medications

Medication

Some Side Effects

Biguanides

All biguanides can cause

  • Diarrhea

  • Increased acidity of body fluids (rare)

  • Liver failure (rare)

MetforminMetformin

Extended-release metforminExtended-release metformin

Sulfonylureas

All sulfonylureas can cause

  • Weight gain

  • Low blood glucose levels

Acetohexamide

Diarrhea

Nausea

Fluid retention (edema)

Chlorpropamide

Low sodium in blood

GlimepirideGlimepiride

Dizziness

Headache

GlipizideGlipizide

Diarrhea

Nausea

Low blood count (anemia)

Glipizide, extended releaseGlipizide, extended release

Diarrhea

Nausea

GlyburideGlyburide

Indigestion

Micronized glyburideMicronized glyburide

Indigestion

TolazamideTolazamide

Nausea

Vomiting

TolbutamideTolbutamide

Headache

Low blood count

Meglitinides

All meglitinides can cause

  • Low blood glucose levels

NateglinideNateglinide

Minimal weight gain

RepaglinideRepaglinide

Thiazolidinediones

All thiazolidinediones can cause

  • Weight gain

  • Fluid retention (edema)

  • Increased risk of fractures

PioglitazonePioglitazone

Possible increased risk of bladder cancer

RosiglitazoneRosiglitazone

Possible increase in heart attacks

Alpha-glucosidase inhibitors

All alpha-glucosidase inhibitors can cause

  • Diarrhea

  • Abdominal pain

  • Bloating

  • Gas

AcarboseAcarbose

MiglitolMiglitol

Dipeptidyl peptidase-4 inhibitors

All dipeptidyl peptidase-4 inhibitors can cause

  • Headache

  • Upper respiratory infection

  • Increased risk of inflammation of the pancreas (pancreatitis)

AlogliptinAlogliptin

Joint pain

LinagliptinLinagliptin

Diarrhea

SaxagliptinSaxagliptin

Joint pain

SitagliptinSitagliptin

Diarrhea

Joint pain

Sodium-glucose co-transporter-2 (SGLT2) inhibitors

All sodium-glucose co-transporter-2 (SGLT2) inhibitors can

SGLT2 inhibitors may possibly

  • Increase the risk of fractures

  • Increase the risk of diabetic ketoacidosis

  • Increase cholesterol levels

  • Increase risk of a life-threatening infection of the area around the genitals (Fournier gangrene)

BexagliflozinBexagliflozin

CanagliflozinCanagliflozin

Increased risk of amputations (rare)

DapagliflozinDapagliflozin

EmpagliflozinEmpagliflozin

ErtugliflozinErtugliflozin